Universal Health Services to Present at March Healthcare Conferences

Universal Health Services, Inc. (UHS) has announced that Steve Filton, Executive Vice President and Chief Financial Officer, will present at several upcoming healthcare conferences in March. The presentations will provide an opportunity for investors and analysts to gain insights into the company's financial performance, strategic initiatives, and future outlook.



The first presentation will take place on Monday, March 3, 2025, at 9:10 AM (ET) at the TD Cowen 45th Annual Health Care Conference in Boston, MA. Filton will also present at the Leerink Partners 27th Annual Global Healthcare Conference in Miami Beach, FL on Monday, March 10, 2025, at 1:00 PM (ET). Additionally, he will speak at Barclays 27th Annual Global Healthcare Conference in Miami Beach, FL on Tuesday, March 11, 2025, at 8:50 AM (ET).

Live audio webcasts of the presentations will be available on the company's website (www.uhs.com). For those unable to listen to the live webcasts, replays of the presentations will be available on the website for 90 days following the conferences.

Universal Health Services, Inc. is one of the nation's largest providers of hospital and healthcare services. Through its subsidiaries, UHS operates acute care hospitals, behavioral health facilities, outpatient facilities, and ambulatory care access points located throughout the United States, Puerto Rico, and the United Kingdom. The company's hospitals offer a wide range of services, including general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and behavioral health services.



In recent years, UHS has experienced significant revenue and earnings growth. In 2023, the company's revenue was $14.28 billion, an increase of 6.59% compared to the previous year's $13.40 billion. Earnings were $717.49 million, an increase of 6.32%. This growth can be attributed to the company's strong operational performance, strategic acquisitions, and expansion of services.

Analysts have a positive outlook on UHS, with an average rating of "Buy" and a 12-month stock price forecast of $222.59, which represents an increase of 23.64% from the latest price of $180.03. The company's strong financial performance, combined with its diversified business model and growth prospects, makes it an attractive investment opportunity for those seeking exposure to the healthcare sector.

In conclusion, Universal Health Services' upcoming presentations at major healthcare conferences provide an excellent opportunity for investors and analysts to learn more about the company's financial performance, strategic initiatives, and future outlook. With a strong track record of growth and a positive outlook from analysts, UHS is well-positioned to continue its success in the healthcare sector.